Stock listing
Tokyo:4565 Nxera Pharma Co., Ltd. (ネクセラファーマ) 株価
Home listing (Tokyo) of Nxera Pharma Co., Ltd.
Follow Nxera Pharma Co., Ltd. into a list and get an email when it puts out news.

- Ticker
- Tokyo:4565
- Asset type
- Stock
- Exchange
- Tokyo
- Currency
- JPY
What changed lately
Latest news release · Oct 14, 2026
Nxera Pharma Enters into Exclusive License, Supply and Commercialization Agreement with Synmosa for QUVIVIQ Across Eight Asia-Pacific Markets
Latest earnings call · Aug 7, 2026
Nxera Pharma (Tokyo:4565) Q2 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 54 slides
Calls
Replays
Nxera Pharma (Tokyo:4565) Q2 2026 Earnings Call
Fri, Aug 07, 2026 · 4:00 AM ET
Watch TranscriptNxera Pharma (Tokyo:4565) Q4 2025 Earnings Call
Fri, Feb 13, 2026 · 3:00 AM ET
Watch TranscriptNxera Pharma (Tokyo:4565) Q2 2025 Earnings Call
Fri, Aug 08, 2025
Watch Transcript
Latest news
Decks
Investor Presentation (October 2026)
Investor deck · 54 slides · October 2026
H1 2026 Earnings Presentation
Earnings · 33 slides · Aug 7, 2026
Investor Presentation (June 2026)
Investor deck · 53 slides · June 2026
Investor Presentation (May 2026)
Investor deck · 54 slides · May 2026
Nxera Pharma Co., Ltd. on 6ix
- News releases
- 43 in the last 12 months · 52 in all · newest Oct 14, 2026 · oldest 2025
- Calls
- 9 calls with a replay · 9 with a transcript · latest Aug 7, 2026
- Decks
- 67 decks · latest October 2026
Where Nxera Pharma Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4565 ネクセラファーマ · Home listing · This page | Tokyo | Japan | JPY |
| OTC:SOLTF | OTC | United States | USD |
| LS Exchange:A0B7EK | LS Exchange | Germany | EUR |
| gettex:JSS | gettex | Germany | EUR |
| Lang & Schwarz:A0B7EK | Lang & Schwarz | Germany | EUR |
| Dusseldorf:JSS | Dusseldorf | Germany | EUR |
| Frankfurt:JSS | Frankfurt | Germany | EUR |
| Munich:JSS | Munich | Germany | EUR |
| Stuttgart:JSS | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Nxera Pharma Co., Ltd.